002390.SZ
002390.SZ
CNE100000NG5
XINBANG PHAR.
Loading chart...

Company Profile

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological, and anti-infective drugs and medications. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China.

Related stocks

000915.SZ
000915.SZ • China
WIT DYNE
24.22 CNY
849.25M USD 1Y -23.8%
600829.SS
600829.SS • China
HPGC RENMINTONGTAI PHARMACEUTIC
9.52 CNY
826.06M USD 1Y +19.9%
000566.SZ
000566.SZ • China
HAINAN HAIYAO
4.71 CNY
914.35M USD 1Y -13.7%
300039.SZ
300039.SZ • China
SHANGHAI KAIBAO
5.39 CNY
843.62M USD 1Y -11.8%
000597.SZ
000597.SZ • China
NEP.
4.91 CNY
1.05B USD 1Y -10.2%
688276.SS
688276.SS • China
CHANGCHUN BCHT BIOTECHNOLOGY CO
17.79 CNY
1.1B USD 1Y -19.6%
600252.SS
600252.SS • China
GUANGXI WUZHOU ZHONGHENG GROUP
2.25 CNY
1.07B USD 1Y -17.6%
600351.SS
600351.SS • China
YABAO PHARMACEUTICAL GROUP CO L
7.07 CNY
732.07M USD 1Y +6.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
36.4% p.a.
Max Drawdown (5Y)
-66.4%
Sharpe Ratio (5Y)
-0.54
Beta Factor
0.08
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 50.2 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (36.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -78.1% in the extended horizon.
ende